Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.
Title | Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Avgerinos, I., Karagiannis T., Matthews D. R., Tsapas A., & Bekiari E. |
Journal | Diabetes Obes Metab |
Volume | 25 |
Issue | 10 |
Pagination | 3020-3029 |
Date Published | 2023 Oct |
ISSN | 1463-1326 |
Keywords | Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Glucose, Heart Failure, Humans, Hyperkalemia, Sodium, Sodium-Glucose Transporter 2 Inhibitors, Symporters |
Abstract | AIM: To explore whether the beneficial cardiovascular (CV) effect of sodium-glucose co-transporter-2 (SGLT-2) inhibitors is consistent with or without concurrent use of CV medications in patients with type 2 diabetes, heart failure (HF) or chronic kidney disease. |
DOI | 10.1111/dom.15200 |
Alternate Journal | Diabetes Obes Metab |
PubMed ID | 37435776 |